Local vascular responses affecting blood flow in postural tachycardia syndrome

被引:52
|
作者
Stewart, JM
Medow, MS
Montgomery, LD
机构
[1] New York Med Coll, Ctr Pediat Hypotens, Dept Pediat, Valhalla, NY 10595 USA
[2] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA
[3] LDM Associates, San Jose, CA 95126 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2003年 / 285卷 / 06期
关键词
myogenic vasoconstriction; venoarteriolar vasoconstriction; autonomic vasoconstriction;
D O I
10.1152/ajpheart.00429.2003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Postural tachycardia syndrome (POTS) is defined by orthostatic intolerance associated with abnormal upright tachycardia. Some patients have defective peripheral vasoconstriction and increased calf blood flow. Others have increased peripheral arterial resistance and decreased blood flow. In 14 POTS patients (13-19 yr) evenly subdivided among low-flow POTS (LFP) and high-flow POTS (HFP) we tested the hypothesis that myogenic, venoarteriolar, and reactive hyperemic responses are abnormal. We used venous occlusion plethysmography to measure calf venous pressure and blood flow in the supine position and when the calf was lowered by 40 cm to evoke myogenic and venoarteriolar responses and during venous hypertension by 40-mmHg occlusion to evoke the venoarteriolar response. We measured calf reactive hyperemia with plethysmography and cutaneous laser-Doppler flowmetry. Baseline blood flow in LFP was reduced compared with HFP and control subjects (0.8 +/- 0.2 vs. 4.4 +/- 0.5 and 2.7 +/- 0.4 ml.min(-1).100 ml(-1)) but increased during leg lowering (1.2 +/- 0.5 ml.min(-1).100 ml(-1)) while decreasing in the others. Baseline peripheral arterial resistance was increased in LFP and decreased in HFP compared with control subjects (39 +/- 13 vs. 15 +/- 3 and 22 +/- 5 mmHg.ml(-1).100 ml.min) but decreased to 29 +/- 13 mmHg.ml(-1).100 ml.min in LFP during venous hypertension. Resistance increased in the other groups. Maximum calf hyperemic flow and cutaneous flow were similar in all subjects. The duration of hyperemic blood flow was curtailed in LFP compared with either control or HFP subjects ( plethysmographic time constant = 20 +/- 2 vs. 29 +/- 4 and 28 +/- 4 s; cutaneous time constant = 60 +/- 25 vs. 149 +/- 53 s in controls). Local blood flow regulation in low-flow POTS is impaired.
引用
收藏
页码:H2749 / H2756
页数:8
相关论文
共 50 条
  • [21] Assessment of Vascular Endothelial Function in Postural Tachycardia Syndrome and Healthy Controls
    Celedonio, Jorge
    Nwazue, Victor
    Figueroa, Rocio
    Paranjape, Sachin
    Black, Bonnie
    Garland, Emily
    Okamoto, Luis
    Robertson, David
    Diedrich, Andre'
    Raj, Satish
    Shibao, Cyndya
    Biaggioni, Italo
    Gamboa, Alfredo
    HYPERTENSION, 2016, 68
  • [22] Vascular perturbations in the chronic orthostatic intolerance of the postural orthostatic tachycardia syndrome
    Stewart, JM
    Weldon, A
    JOURNAL OF APPLIED PHYSIOLOGY, 2000, 89 (04) : 1505 - 1512
  • [23] Decreased skeletal muscle pump activity in patients with postural tachycardia syndrome and low peripheral blood flow
    Stewart, JM
    Medow, MS
    Montgomery, LD
    McLeod, K
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 286 (03): : H1216 - H1222
  • [24] Reduced Cerebral Blood Flow With Orthostasis Precedes Hypocapnic Hyperpnea, Sympathetic Activation, and Postural Tachycardia Syndrome
    Del Pozzi, Andrew T.
    Schwartz, Christopher E.
    Tewari, Deepali
    Medow, Marvin S.
    Stewart, Julian M.
    HYPERTENSION, 2014, 63 (06) : 1302 - 1308
  • [25] Decreased skeletal muscle pump activity in postural tachycardia syndrome patients with low peripheral blood flow
    Stewart, JM
    Medow, MS
    Montgomery, LD
    McLeod, KJ
    FASEB JOURNAL, 2004, 18 (04): : A663 - A663
  • [26] Cardiac responses to exercise distinguish postural orthostatic tachycardia syndrome variants
    Pianosi, Paolo T.
    Schroeder, Darrell R.
    Fischer, Philip R.
    PHYSIOLOGICAL REPORTS, 2016, 4 (22):
  • [27] Mechanisms of postural tachycardia syndrome
    Inoue, H
    INTERNAL MEDICINE, 2001, 40 (10) : 983 - 984
  • [28] Pharmacotherapy for postural tachycardia syndrome
    Miller, Amanda J.
    Raj, Satish R.
    AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2018, 215 : 28 - 36
  • [29] The neuropathic postural tachycardia syndrome
    Jacob, G
    Costa, F
    Shannon, JR
    Robertson, RM
    Wathen, M
    Stein, M
    Biaggioni, I
    Ertl, A
    Black, B
    Robertson, D
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (14): : 1008 - 1014
  • [30] Neuropathic postural tachycardia syndrome
    不详
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2000, 11 (12) : 1423 - 1423